Involvement of sialoglycans in SARS-COV-2 infection: Opportunities and challenges for glyco-based inhibitors
Viral infections have been the causes of global pandemics, including the ongoing coronavirus disease 2019, which prompted the investigation into the infection mechanisms to find treatment and aid the vaccine design. Betacoronaviruses use spike glycoprotein on their surface to bind to host receptors,...
Saved in:
Main Author: | Kuhaudomlarp S. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/87113 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
by: Tomic A.
Published: (2023) -
Solanaceae Family Phytochemicals as Inhibitors of 3C-Like Protease of SARS-CoV-2: An In Silico Analysis
by: Mahmood R.A.
Published: (2023) -
Anti-SARS-CoV-2 activity of extracellular vesicle inhibitors: Screening, validation, and combination with remdesivir
by: Supasek Kongsomros, et al.
Published: (2022) -
The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern
by: Rana Abdelnabi, et al.
Published: (2022) -
Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies
by: Nutho B.
Published: (2023)